Suggestions
Andreas Norlin
Drug Discovery and Development - Strategy and Execution
Andreas Norlin is a professional with over 20 years of experience in research, pre-clinical and clinical development across academia, biotech, and big pharma. His expertise lies in drug development strategy and execution, particularly in diabetes, inflammatory disease, and drug delivery technologies. He has a strong background in R&D management, project management, people leadership, line management, and external collaborations. Andreas' leadership style is people-oriented, focusing on patients' needs and team visibility. He prioritizes making fact-based decisions and maintaining focus on critical aspects of projects. He is well-versed in various areas including project valuation, regulatory affairs, company directorship, budgeting, leadership development, coaching, risk assessment, portfolio management, and more. His educational background includes studies in Medical Marketing Strategy, Strategy Execution, Managing Medical Product Innovation, a Ph.D. in Animal Physiology, an MSc in Biology, and Philosophy studies.
